Moderna raises its revenue outlook — but all eyes are on what happens next with its experimental cancer vaccine
At a glance
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
- Primary source
- MarketWatch.com - Top Stories — Read original article
- Published
- Topic
- Finance
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
This summary comes from MarketWatch.com - Top Stories. Read the full article at the original source.
References
More in Finance
Elon Musk opens the door for a big SpaceX acquisition
The rocket and satellite-internet company is looking to challenge telecom giants.
‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?
“Sometimes I wonder whether wealthier Americans should trade places with people like me.”
Data centers run on debt. That was a problem for bonds this year — and it’s only going to get worse.
AI debt issuance this year overwhelmed investor portfolios, and has disappointed from a performance perspective. The funding need won’t get any better with Democrats in control of…
Nvidia, AMD and other chip stocks rebound — but is relief from the ‘violent’ selloff only temporary?
Analysts warn of further volatility ahead, although there are several new factors that work in the AI trade’s favor.